Diabetes in midlife and cognitive change over 20 years

A cohort study

Andreea M. Rawlings, A. Richey Sharrett, Andrea L C Schneider, Josef Coresh, Marilyn Albert, David Couper, Michael Griswold, Rebecca F Gottesman, Lynne E. Wagenknecht, B. Gwen Windham, Elizabeth Selvin

Research output: Contribution to journalArticle

Abstract

Background: Type 2 diabetes is associated with dementia risk, but evidence is limited for possible associations of diabetes and prediabetes with cognitive decline. Objective: To determine whether diabetes in midlife is associated with 20-year cognitive decline and to characterize long-term cognitive decline across clinical categories of hemoglobin A1c (HbA1c) levels. Design: Prospective cohort study. Setting: The community-based ARIC (Atherosclerosis Risk in Communities) study. Participants: 13 351 black and white adults aged 48 to 67 years at baseline (1990 to 1992). Measurements: Diabetes was defined by self-reported physician diagnosis or medication use or HbA1c level of 6.5% or greater. Undiagnosed diabetes, prediabetes, and glucose control in persons with diagnosed diabetes were defined by clinical categories of HbA1c level. Delayed word recall, digit symbol substitution, and word fluency tests were used to assess cognitive performance and were summarized with a global Z score. Results: Diabetes in midlife was associated with a 19% greater cognitive decline over 20 years (adjusted global Z-score difference, -0.15 [95% CI, -0.22 to -0.08]) compared with no diabetes. Cognitive decline was significantly greater among persons with prediabetes (HbA1c level of 5.7% to 6.4%) than among those with an HbA1c level less than 5.7%. Participants with poorly controlled diabetes (HbA1c level ≥;7.0%) had greater decline than those whose diabetes was controlled (adjusted global Z-score difference, -0.16; P = 0.071). Longer-duration diabetes was also associated with greater late-life cognitive decline (P for trend 〈 0.001). Rates of decline did not differ significantly between white and black persons (P for interaction = 0.44). Limitation: Single HbA1c measurement at baseline, 1 test per cognitive domain, and potential geographic confounding of race comparisons. Conclusion: Diabetes prevention and glucose control in midlife may protect against late-life cognitive decline.

Original languageEnglish (US)
Pages (from-to)785-793
Number of pages9
JournalAnnals of Internal Medicine
Volume161
Issue number11
DOIs
StatePublished - Dec 2 2014

Fingerprint

Hemoglobins
Cohort Studies
Prediabetic State
Glucose
Cognitive Dysfunction
Type 2 Diabetes Mellitus
Dementia
Atherosclerosis
Prospective Studies
Physicians
hydroquinone

ASJC Scopus subject areas

  • Internal Medicine
  • Medicine(all)

Cite this

Diabetes in midlife and cognitive change over 20 years : A cohort study. / Rawlings, Andreea M.; Sharrett, A. Richey; Schneider, Andrea L C; Coresh, Josef; Albert, Marilyn; Couper, David; Griswold, Michael; Gottesman, Rebecca F; Wagenknecht, Lynne E.; Windham, B. Gwen; Selvin, Elizabeth.

In: Annals of Internal Medicine, Vol. 161, No. 11, 02.12.2014, p. 785-793.

Research output: Contribution to journalArticle

Rawlings, AM, Sharrett, AR, Schneider, ALC, Coresh, J, Albert, M, Couper, D, Griswold, M, Gottesman, RF, Wagenknecht, LE, Windham, BG & Selvin, E 2014, 'Diabetes in midlife and cognitive change over 20 years: A cohort study', Annals of Internal Medicine, vol. 161, no. 11, pp. 785-793. https://doi.org/10.7326/M14-0737
Rawlings, Andreea M. ; Sharrett, A. Richey ; Schneider, Andrea L C ; Coresh, Josef ; Albert, Marilyn ; Couper, David ; Griswold, Michael ; Gottesman, Rebecca F ; Wagenknecht, Lynne E. ; Windham, B. Gwen ; Selvin, Elizabeth. / Diabetes in midlife and cognitive change over 20 years : A cohort study. In: Annals of Internal Medicine. 2014 ; Vol. 161, No. 11. pp. 785-793.
@article{c33b3366a10e4795be27c5ab28506e76,
title = "Diabetes in midlife and cognitive change over 20 years: A cohort study",
abstract = "Background: Type 2 diabetes is associated with dementia risk, but evidence is limited for possible associations of diabetes and prediabetes with cognitive decline. Objective: To determine whether diabetes in midlife is associated with 20-year cognitive decline and to characterize long-term cognitive decline across clinical categories of hemoglobin A1c (HbA1c) levels. Design: Prospective cohort study. Setting: The community-based ARIC (Atherosclerosis Risk in Communities) study. Participants: 13 351 black and white adults aged 48 to 67 years at baseline (1990 to 1992). Measurements: Diabetes was defined by self-reported physician diagnosis or medication use or HbA1c level of 6.5{\%} or greater. Undiagnosed diabetes, prediabetes, and glucose control in persons with diagnosed diabetes were defined by clinical categories of HbA1c level. Delayed word recall, digit symbol substitution, and word fluency tests were used to assess cognitive performance and were summarized with a global Z score. Results: Diabetes in midlife was associated with a 19{\%} greater cognitive decline over 20 years (adjusted global Z-score difference, -0.15 [95{\%} CI, -0.22 to -0.08]) compared with no diabetes. Cognitive decline was significantly greater among persons with prediabetes (HbA1c level of 5.7{\%} to 6.4{\%}) than among those with an HbA1c level less than 5.7{\%}. Participants with poorly controlled diabetes (HbA1c level ≥;7.0{\%}) had greater decline than those whose diabetes was controlled (adjusted global Z-score difference, -0.16; P = 0.071). Longer-duration diabetes was also associated with greater late-life cognitive decline (P for trend 〈 0.001). Rates of decline did not differ significantly between white and black persons (P for interaction = 0.44). Limitation: Single HbA1c measurement at baseline, 1 test per cognitive domain, and potential geographic confounding of race comparisons. Conclusion: Diabetes prevention and glucose control in midlife may protect against late-life cognitive decline.",
author = "Rawlings, {Andreea M.} and Sharrett, {A. Richey} and Schneider, {Andrea L C} and Josef Coresh and Marilyn Albert and David Couper and Michael Griswold and Gottesman, {Rebecca F} and Wagenknecht, {Lynne E.} and Windham, {B. Gwen} and Elizabeth Selvin",
year = "2014",
month = "12",
day = "2",
doi = "10.7326/M14-0737",
language = "English (US)",
volume = "161",
pages = "785--793",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "11",

}

TY - JOUR

T1 - Diabetes in midlife and cognitive change over 20 years

T2 - A cohort study

AU - Rawlings, Andreea M.

AU - Sharrett, A. Richey

AU - Schneider, Andrea L C

AU - Coresh, Josef

AU - Albert, Marilyn

AU - Couper, David

AU - Griswold, Michael

AU - Gottesman, Rebecca F

AU - Wagenknecht, Lynne E.

AU - Windham, B. Gwen

AU - Selvin, Elizabeth

PY - 2014/12/2

Y1 - 2014/12/2

N2 - Background: Type 2 diabetes is associated with dementia risk, but evidence is limited for possible associations of diabetes and prediabetes with cognitive decline. Objective: To determine whether diabetes in midlife is associated with 20-year cognitive decline and to characterize long-term cognitive decline across clinical categories of hemoglobin A1c (HbA1c) levels. Design: Prospective cohort study. Setting: The community-based ARIC (Atherosclerosis Risk in Communities) study. Participants: 13 351 black and white adults aged 48 to 67 years at baseline (1990 to 1992). Measurements: Diabetes was defined by self-reported physician diagnosis or medication use or HbA1c level of 6.5% or greater. Undiagnosed diabetes, prediabetes, and glucose control in persons with diagnosed diabetes were defined by clinical categories of HbA1c level. Delayed word recall, digit symbol substitution, and word fluency tests were used to assess cognitive performance and were summarized with a global Z score. Results: Diabetes in midlife was associated with a 19% greater cognitive decline over 20 years (adjusted global Z-score difference, -0.15 [95% CI, -0.22 to -0.08]) compared with no diabetes. Cognitive decline was significantly greater among persons with prediabetes (HbA1c level of 5.7% to 6.4%) than among those with an HbA1c level less than 5.7%. Participants with poorly controlled diabetes (HbA1c level ≥;7.0%) had greater decline than those whose diabetes was controlled (adjusted global Z-score difference, -0.16; P = 0.071). Longer-duration diabetes was also associated with greater late-life cognitive decline (P for trend 〈 0.001). Rates of decline did not differ significantly between white and black persons (P for interaction = 0.44). Limitation: Single HbA1c measurement at baseline, 1 test per cognitive domain, and potential geographic confounding of race comparisons. Conclusion: Diabetes prevention and glucose control in midlife may protect against late-life cognitive decline.

AB - Background: Type 2 diabetes is associated with dementia risk, but evidence is limited for possible associations of diabetes and prediabetes with cognitive decline. Objective: To determine whether diabetes in midlife is associated with 20-year cognitive decline and to characterize long-term cognitive decline across clinical categories of hemoglobin A1c (HbA1c) levels. Design: Prospective cohort study. Setting: The community-based ARIC (Atherosclerosis Risk in Communities) study. Participants: 13 351 black and white adults aged 48 to 67 years at baseline (1990 to 1992). Measurements: Diabetes was defined by self-reported physician diagnosis or medication use or HbA1c level of 6.5% or greater. Undiagnosed diabetes, prediabetes, and glucose control in persons with diagnosed diabetes were defined by clinical categories of HbA1c level. Delayed word recall, digit symbol substitution, and word fluency tests were used to assess cognitive performance and were summarized with a global Z score. Results: Diabetes in midlife was associated with a 19% greater cognitive decline over 20 years (adjusted global Z-score difference, -0.15 [95% CI, -0.22 to -0.08]) compared with no diabetes. Cognitive decline was significantly greater among persons with prediabetes (HbA1c level of 5.7% to 6.4%) than among those with an HbA1c level less than 5.7%. Participants with poorly controlled diabetes (HbA1c level ≥;7.0%) had greater decline than those whose diabetes was controlled (adjusted global Z-score difference, -0.16; P = 0.071). Longer-duration diabetes was also associated with greater late-life cognitive decline (P for trend 〈 0.001). Rates of decline did not differ significantly between white and black persons (P for interaction = 0.44). Limitation: Single HbA1c measurement at baseline, 1 test per cognitive domain, and potential geographic confounding of race comparisons. Conclusion: Diabetes prevention and glucose control in midlife may protect against late-life cognitive decline.

UR - http://www.scopus.com/inward/record.url?scp=84919491272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919491272&partnerID=8YFLogxK

U2 - 10.7326/M14-0737

DO - 10.7326/M14-0737

M3 - Article

VL - 161

SP - 785

EP - 793

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 11

ER -